Literature DB >> 1691738

Control of acid secretion.

M L Schubert1, R D Shamburek.   

Abstract

Receptors for the main neural (acetylcholine), hormonal (gastrin) and paracrine (histamine) secretory stimulants and the signal transduction pathways to which these receptors are coupled have been identified on the parietal cell. The stimulatory effect of histamine is mediated via an increase in adenylate cyclase activity, whereas the effect of acetylcholine and gastrin are mediated via an increase in cytosolic levels of calcium. Strong synergism between histamine and either gastrin or acetylcholine may reflect postreceptor interaction between the distinct pathways. Acetylcholine and gastrin are also capable of releasing histamine from the gastric mucosa, probably from ECL cells. The inhibitory effects of somatostatin and prostaglandin E on acid secretion are mediated by receptors coupled via guanine nucleotide binding proteins to inhibition of adenylate cyclase activity. All the pathways converge on and modulate the activity of the luminal enzyme, H+K(+)-ATPase, ultimately responsible for acid secretion. The intramural neural and paracrine pathways involved in the regulation of gastrin secretion in the antrum and acid secretion in the fundus have also been identified. Of prime importance is the somatostatin cell, which exerts a paracrine restraint on gastrin secretion and acid secretion. Elimination of this restraint or disinhibition is one of the mechanisms by which the stimulatory influence of cholinergic neurons is exerted on gastrin and parietal cells. Gastrin secretion is regulated by a cholinergic neuron that causes inhibition of somatostatin secretion and thus stimulation of gastrin secretion (disinhibition) and a noncholinergic neuron that causes direct stimulation of gastrin secretion by releasing the neurotransmitter, bombesin (or gastrin-releasing peptide). Acid secretion is regulated by a cholinergic neuron that causes direct stimulation of the parietal cell and indirect stimulation by decreasing somatostatin secretion, thus eliminating its inhibitory effect on the parietal cell (disinhibition). In addition, a regulatory feedback mechanism exists whereby intraluminal acidification stimulates somatostatin secretion, which in turn attenuates acid secretion. Gastric acid secretion may also be regulated by one or more intestinal inhibitory hormones, the most likely candidates being secretin, intestinal somatostatin, and neurotensin. Enterogastrone activity probably reflects the combined effect of all these hormones. Precise information on receptors and signal transduction mechanisms as well as on intramural neural and paracrine regulatory pathways has led to the development of new drugs capable of inhibiting acid secretion. These include antagonists that interact with stimulatory receptors (histamine H2-receptor antagonists, muscarinic receptor antagonists, and gastrin receptor antagonists), agonists that interact with inhibitory receptors (somatostatin and prostaglandin E analogues), and irreversible inhibitors of the luminal enzyme, H+K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691738

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

1.  Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma.

Authors:  Makoto Ishikawa; Joji Kitayama; Shoichi Kaizaki; Hiroshi Nakayama; Hironori Ishigami; Shin Fujii; Hiroyuki Suzuki; Tomomi Inoue; Akihiro Sako; Masahiro Asakage; Hiroharu Yamashita; Kenji Hatono; Hirokazu Nagawa
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

Review 2.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 3.  Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract.

Authors:  Keith A Sharkey; Tor C Savidge
Journal:  Auton Neurosci       Date:  2013-12-22       Impact factor: 3.145

4.  The use of omeprazole to alleviate stomach ulcers in swine during periods of feed withdrawal.

Authors:  R M Friendship; S I Melnichouk; C E Dewey
Journal:  Can Vet J       Date:  2000-12       Impact factor: 1.008

5.  Use of acetylcholine (Ach) for spreading metaphase chromosomes and application to the cytogenetic analysis of human stomach cancers.

Authors:  K Sasai; T Nakada; R Tanaka; M Kawamura; T Nakanishi
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

6.  Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects.

Authors:  G Lux; J Hagel; P Bäcker; G Bäcker; R Vogl; H Ruppin; S Domschke; W Domschke
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

Review 7.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Vanillin abrogates ethanol induced gastric injury in rats via modulation of gastric secretion, oxidative stress and inflammation.

Authors:  Abdulrahman Al Asmari; Hamoud Al Shahrani; Nasser Al Masri; Ahmed Al Faraidi; Ibrahim Elfaki; Mohammed Arshaduddin
Journal:  Toxicol Rep       Date:  2015-12-12

9.  Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.

Authors:  Matteo Runfola; Simone Rossi; Simona Panunzi; Pier Luigi Spada; Daniele Gui
Journal:  BMC Gastroenterol       Date:  2003-09-10       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.